AU Stock MarketDetailed Quotes
RADO Radiopharm Theranostics Ltd
- 0.012
- +0.004+50.00%
20min DelayMarket Closed Jul 12 15:43 AET
12.69MMarket Cap0.00P/E (Static)
0.012High0.012Low20.00KVolume0.012Open0.008Pre Close240.00Turnover0.04352wk High0.01%Turnover Ratio1.06BShares0.00752wk Low--EPS TTM2.58MFloat Cap0.070Historical High0.00P/E (Static)214.93MShs Float0.007Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
About Radiopharm Theranostics Ltd Company
Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.
Company Profile
SymbolRADO
Company NameRadiopharm Theranostics Ltd
Founded2021
MarketASX
Fiscal Year Ends06-30
Address62 Lygon Street Level 3, Carlton South
CityMelbourne
CountryAustralia
Zip Code3053
Phone+61 398245254
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
02 9698 5414
Company Executives
- Name
- Position
- Salary
- Riccardo Canevari
- Chief Executive Officer, Managing Director and Executive Director
- --
- David Mozley
- Chief Medical Officer
- --
- Vittorio Puppo
- Chief Operating Officer
- --
- Thom Tulip
- Chief Business Officer
- --
- Paul Alex Hopper
- Executive Chairman of the Board
- --
- Michael Baker
- Non-Executive Director
- --
- Leila Alland
- Non-Executive Director
- --
- Ian Turner
- Non-Executive Director
- --
- Hester Larkin
- Non-Executive Director
- --
- Nathan Jong
- Joint Company Secretary
- --
- Phillip Hains
- Joint Company Secretary
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg